These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1494679)

  • 1. [Oral contrast media in the study of the esophagus with magnetic resonance. Proposal of a new preparation].
    Squillaci E; Fanucci E; Crecco M; Grandinetti ML; Cecconi L; Squillaci S; Simonetti G; Mattioli M; Vitali L
    Radiol Med; 1992 Dec; 84(6):761-6. PubMed ID: 1494679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance imaging of the esophagus with lumen opacification using a specific contrast agent].
    Pavone P; Cardone GP; Di Girolamo M; Catalano C; Albertini Petroni G; Cisternino S; Innacoli M; Aytan E; Passariello R
    Radiol Med; 1992 Dec; 84(6):756-60. PubMed ID: 1494678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadopentetate dimeglumine-barium paste for opacification of the esophageal lumen on MR images.
    Pavone P; Cardone GP; Cisternino S; Di Girolamo M; Aytan E; Passariello R
    AJR Am J Roentgenol; 1992 Oct; 159(4):762-4. PubMed ID: 1529838
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approval from the Food and Drug Administration for unapproved use of an approved drug or device.
    Bates BF
    AJR Am J Roentgenol; 1994 Sep; 163(3):748; author reply 748-9. PubMed ID: 8079894
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging with Gd-DTPA in lesions of the head and neck.
    Vogl Th; Dresel S; Juergens M; Assal J; Lissner J
    J Otolaryngol; 1993 Aug; 22(4):220-30. PubMed ID: 8230372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
    van Bree H; Van Ryssen B; Degryse H; Ramon F
    Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Agnoli AL; Herrmann S
    Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.
    Mihara F; Gupta KL; Joslyn JN
    Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles.
    Faber SC; Stehling MK; Holzknecht N; Gauger J; Helmberger T; Reiser M
    Radiology; 1997 Oct; 205(1):278-82. PubMed ID: 9315000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.